Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
188 hedge funds and large institutions have $1.74B invested in Amedisys in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 15 closing their positions.
167% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 15
40% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 53
37% more call options, than puts
Call options by funds: $2.52M | Put options by funds: $1.84M
15% more funds holding
Funds holding: 163 → 188 (+25)
1.47% more ownership
Funds ownership: 95.97% → 97.44% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $1.82B → $1.74B (-$74.7M)
Top Buyers
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$30.3M |
| 2 |
Millennium Management
New York
|
+$23M |
| 3 |
O
OrbiMed
New York
|
+$10.9M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$10.2M |
| 5 |
EOJOAM
E. Ohman J:or Asset Management
Stockholm,
Sweden
|
+$8.72M |
Top Sellers
| 1 |
BlackRock
New York
|
-$31.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$28.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$21M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$15.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$14.6M |
AMED Hedge Fund Activity: Q4 2017 in Review
188 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2017, worth a combined $1.74B — down 4.1% from $1.82B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new AMED positions and 15 closed out — a net gain of 25 holders — while 74 added to existing stakes and 53 trimmed.
The largest buyer was Columbia Wanger Asset Management, adding an estimated $30.3M. The largest seller was BlackRock, cutting an estimated $31.7M.
- 188 institutional investors held Amedisys (AMED) as of Q4 2017, up from 163 in Q3 2017.
- Funds reported $1.74B of Amedisys stock for Q4 2017, down 4.1% quarter-over-quarter.
- 40 funds opened new Amedisys positions in Q4 2017 and 15 closed out, a net change of +25 holders.
- The largest Amedisys buyer in Q4 2017 was Columbia Wanger Asset Management, an estimated $30.3M added.
- The largest Amedisys seller in Q4 2017 was BlackRock, an estimated $31.7M sold.
Based on aggregated 13F filings for Q4 2017.